Neurological Biomarkers Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

March 2018 | 153 pages | ID: N85D1436159QEN
QYResearch

Abstracts

SUMMARY

This report studies the Neurological Biomarkers market status and outlook of global, from angles of players, regions, product types and end industries; this report analyzes the top players in global market, and splits the Neurological Biomarkers market by product type and application/end industries.

The global Neurological Biomarkers market was XX million US$ in 2017 and is expected to XX million US$ by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Neurological Biomarkers in these regions, from 2013 to 2025 (forecast), covering

• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia and Vietnam))
• South America (Brazil etc.)
• Middle East and Africa (North Africa and GCC Countries)

The major companies in this report including

• Thermo Fisher
• Merck
• Bio-Rad Laboratories
• Roche
• QIAGEN
• Athena Diagnostics
• Myriad RBM
• Cisbio Bioassays
• Wuxi APP
• BGI
• Aepodia
• Genewiz
• Proteome Sciences

By the product type, the market is primarily split into

• Proteomics
• Genomics
• Imaging
• Bioinformatics
• Others

By the end users/application, this report covers the following segments

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

Contents

1 NEUROLOGICAL BIOMARKERS MARKET OVERVIEW

1.1 Neurological Biomarkers Product Overview
1.2 Neurological Biomarkers Market Segment by Type
  1.2.1 Proteomics
  1.2.2 Genomics
  1.2.3 Imaging
  1.2.4 Bioinformatics
  1.2.5 Others
1.3 Global Neurological Biomarkers Market Size by Type
  1.3.1 Global Neurological Biomarkers Sales and Growth by Type
  1.3.2 Global Neurological Biomarkers Sales and Market Share by Type (2013-2018)
  1.3.3 Global Neurological Biomarkers Revenue and Market Share by Type (2013-2018)
  1.3.4 Global Neurological Biomarkers Price by Type (2013-2018)
1.4 North America Neurological Biomarkers by Type
1.5 Europe Neurological Biomarkers by Type
1.6 Asia-Pacific Neurological Biomarkers by Type
1.7 South America Neurological Biomarkers by Type
1.8 Middle East and Africa Neurological Biomarkers by Type

2 GLOBAL NEUROLOGICAL BIOMARKERS MARKET COMPETITION BY COMPANY

2.1 Global Neurological Biomarkers Sales and Market Share by Company (2013-2018)
2.2 Global Neurological Biomarkers Revenue and Share by Company (2013-2018)
2.3 Global Neurological Biomarkers Price by Company (2013-2018)
2.4 Global Top Players Neurological Biomarkers Manufacturing Base Distribution, Sales Area, Product Types
2.5 Neurological Biomarkers Market Competitive Situation and Trends
  2.5.1 Neurological Biomarkers Market Concentration Rate
  2.5.2 Global Neurological Biomarkers Market Share of Top 5 and Top 10 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 NEUROLOGICAL BIOMARKERS COMPANY PROFILES AND SALES DATA

3.1 Thermo Fisher
  3.1.1 Company Basic Information, Manufacturing Base and Competitors
  3.1.2 Neurological Biomarkers Product Category, Application and Specification
  3.1.3 Thermo Fisher Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.1.4 Main Business Overview
3.2 Merck
  3.2.1 Company Basic Information, Manufacturing Base and Competitors
  3.2.2 Neurological Biomarkers Product Category, Application and Specification
  3.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.2.4 Main Business Overview
3.3 Bio-Rad Laboratories
  3.3.1 Company Basic Information, Manufacturing Base and Competitors
  3.3.2 Neurological Biomarkers Product Category, Application and Specification
  3.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.3.4 Main Business Overview
3.4 Roche
  3.4.1 Company Basic Information, Manufacturing Base and Competitors
  3.4.2 Neurological Biomarkers Product Category, Application and Specification
  3.4.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.4.4 Main Business Overview
3.5 QIAGEN
  3.5.1 Company Basic Information, Manufacturing Base and Competitors
  3.5.2 Neurological Biomarkers Product Category, Application and Specification
  3.5.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.5.4 Main Business Overview
3.6 Athena Diagnostics
  3.6.1 Company Basic Information, Manufacturing Base and Competitors
  3.6.2 Neurological Biomarkers Product Category, Application and Specification
  3.6.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.6.4 Main Business Overview
3.7 Myriad RBM
  3.7.1 Company Basic Information, Manufacturing Base and Competitors
  3.7.2 Neurological Biomarkers Product Category, Application and Specification
  3.7.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.7.4 Main Business Overview
3.8 Cisbio Bioassays
  3.8.1 Company Basic Information, Manufacturing Base and Competitors
  3.8.2 Neurological Biomarkers Product Category, Application and Specification
  3.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.8.4 Main Business Overview
3.9 Wuxi APP
  3.9.1 Company Basic Information, Manufacturing Base and Competitors
  3.9.2 Neurological Biomarkers Product Category, Application and Specification
  3.9.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.9.4 Main Business Overview
3.10 BGI
  3.10.1 Company Basic Information, Manufacturing Base and Competitors
  3.10.2 Neurological Biomarkers Product Category, Application and Specification
  3.10.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin(2013-2018)
  3.10.4 Main Business Overview
3.11 Aepodia
3.12 Genewiz
3.13 Proteome Sciences

4 NEUROLOGICAL BIOMARKERS MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Neurological Biomarkers Market Size and CAGR by Regions
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
4.2 Global Neurological Biomarkers Sales and Revenue by Regions
  4.2.1 Global Neurological Biomarkers Sales and Market Share by Regions (2013-2018)
  4.2.2 Global Neurological Biomarkers Revenue and Market Share by Regions (2013-2018)
  4.2.3 Global Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Neurological Biomarkers Sales, Revenue, Price and Gross Margin
  4.3.1 United States
  4.3.2 Canada
  4.3.3 Mexico
4.4 Europe Neurological Biomarkers Sales, Revenue, Price and Gross Margin
  4.4.1 Germany
  4.4.2 UK
  4.4.3 France
  4.4.4 Italy
  4.4.5 Russia
  4.4.6 Turkey
4.5 Asia-Pacific Neurological Biomarkers Sales, Revenue, Price and Gross Margin
  4.5.1 China
  4.5.2 Japan
  4.5.3 Korea
  4.5.4 Southeast Asia
    4.5.4.1 Indonesia
    4.5.4.2 Thailand
    4.5.4.3 Malaysia
    4.5.4.4 Philippines
    4.5.4.5 Vietnam
  4.5.5 India
  4.5.6 Australia
4.6 South America Neurological Biomarkers Sales, Revenue, Price and Gross Margin
  4.6.1 Brazil
4.7 Middle East and Africa Neurological Biomarkers Sales, Revenue, Price and Gross Margin
  4.7.1 North Africa
  4.7.2 GCC Countries

5 NEUROLOGICAL BIOMARKERS APPLICATION/END USERS

5.1 Neurological Biomarkers Segment by Application
  5.1.1 Diagnostics
  5.1.2 Drug Discovery
  5.1.3 Personalized Medicine
  5.1.4 Others
5.2 Global Neurological Biomarkers Product Segment by Application
  5.2.1 Global Neurological Biomarkers Sales by Application
  5.2.2 Global Neurological Biomarkers Sales and Market Share by Application (2013-2018)
5.3 North America Neurological Biomarkers by Application
5.4 Europe Neurological Biomarkers by Application
5.5 Asia-Pacific Neurological Biomarkers by Application
5.6 South America Neurological Biomarkers by Application
5.7 Middle East and Africa Neurological Biomarkers by Application

6 GLOBAL NEUROLOGICAL BIOMARKERS MARKET FORECAST

6.1 Global Neurological Biomarkers Sales, Revenue Forecast (2018-2025)
  6.1.1 Global Neurological Biomarkers Sales and Growth Rate Forecast (2018-2025)
  6.1.1 Global Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Neurological Biomarkers Forecast by Regions
  6.2.1 North America Neurological Biomarkers Sales and Revenue Forecast (2018-2025)
  6.2.2 Europe Neurological Biomarkers Sales and Revenue Forecast (2018-2025)
  6.2.3 Asia-Pacific Neurological Biomarkers Sales and Revenue Forecast (2018-2025)
    6.2.3.1 China
    6.2.3.2 Japan
    6.2.3.3 Korea
    6.2.3.4 Southeast Asia
    6.2.3.5 India
    6.2.3.6 Australia
  6.2.4 South America Neurological Biomarkers Sales and Revenue Forecast (2018-2025)
  6.2.5 Middle East and Africa Neurological Biomarkers Sales and Revenue Forecast (2018-2025)
    6.2.5.1 North Africa
    6.2.5.2 GCC Countries
6.3 Neurological Biomarkers Forecast by Type
  6.3.1 Global Neurological Biomarkers Sales and Revenue Forecast by Type (2018-2025)
  6.3.2 Proteomics Gowth Forecast
  6.3.3 Genomics Gowth Forecast
6.4 Neurological Biomarkers Forecast by Application
  6.4.1 Global Neurological Biomarkers Sales Forecast by Application (2018-2025)
  6.4.2 Global Neurological Biomarkers Forecast in Diagnostics
  6.4.3 Global Neurological Biomarkers Forecast in Drug Discovery

7 NEUROLOGICAL BIOMARKERS UPSTREAM RAW MATERIALS

7.1 Neurological Biomarkers Key Raw Materials
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price
  7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Neurological Biomarkers Industrial Chain Analysis

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers

9 RESEARCH FINDINGS AND CONCLUSION

Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neurological Biomarkers Product Picture
Figure Global Neurological Biomarkers Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Neurological Biomarkers Sales (K Units) Status and Outlook (2013-2025)
Figure Product Picture of Proteomics
Table Major Players of Proteomics
Figure Global Proteomics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Genomics
Table Major Players of Genomics
Figure Global Genomics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Imaging
Table Major Players of Imaging
Figure Global Imaging Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Bioinformatics
Table Major Players of Bioinformatics
Figure Global Bioinformatics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (%)(2013-2018)
Table Global Neurological Biomarkers Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Neurological Biomarkers Sales (K Units) by Type (2013-2018)
Table Global Neurological Biomarkers Sales Share (%) by Type (2013-2018)
Figure Global Neurological Biomarkers Sales Market Share (%) by Type (2013-2018)
Figure Global Neurological Biomarkers Sales Market Share (%) by Type in 2017
Table Global Neurological Biomarkers Revenue (Million USD) by Type (2013-2018)
Table Global Neurological Biomarkers Revenue Share (%) by Type (2013-2018)
Figure Global Neurological Biomarkers Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Neurological Biomarkers Revenue Market Share (%) by Type
Table Global Neurological Biomarkers Price (USD/Unit) by Type (2013-2018)
Table North America Neurological Biomarkers Sales (K Units) by Type (2013-2018)
Table North America Neurological Biomarkers Sales Share by Type (2013-2018)
Figure North America Neurological Biomarkers Sales Market Share by Type (2013-2018)
Figure North America Neurological Biomarkers Sales Market Share by Type in 2017
Table Europe Neurological Biomarkers Sales (K Units) by Type (2013-2018)
Table Europe Neurological Biomarkers Sales Share by Type (2013-2018)
Figure Europe Neurological Biomarkers Sales Market Share by Type (2013-2018)
Figure Europe Neurological Biomarkers Sales Market Share by Type in 2017
Table Asia-Pacific Neurological Biomarkers Sales (K Units) by Type (2013-2018)
Table Asia-Pacific Neurological Biomarkers Sales Share by Type (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Type (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Type in 2017
Table South America Neurological Biomarkers Sales (K Units) by Type (2013-2018)
Table South America Neurological Biomarkers Sales Share by Type (2013-2018)
Figure South America Neurological Biomarkers Sales Market Share by Type (2013-2018)
Figure South America Neurological Biomarkers Sales Market Share by Type in 2017
Table Middle East and Africa Neurological Biomarkers Sales (K Units) by Type (2013-2018)
Table Middle East and Africa Neurological Biomarkers Sales Share by Type (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Type (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Type in 2017
Table Global Neurological Biomarkers Sales (K Units) by Company (2013-2018)
Table Global Neurological Biomarkers Sales Share (%) by Company (2013-2018)
Figure Global Neurological Biomarkers Sales Share (%) by Company in 2017
Table Global Neurological Biomarkers Revenue (Million USD) by Company (2013-2018)
Table Global Neurological Biomarkers Revenue Share (%) by Company (2013-2018)
Figure Global Neurological Biomarkers Revenue Share (%) by Company in 2017
Table Global Market Neurological Biomarkers Average Price (USD/Unit) by Company (2013-2018)
Table Global Neurological Biomarkers Top Players Manufacturing Base Distribution and Sales Area
Table Global Neurological Biomarkers Top Players Product Category
Figure Global Neurological Biomarkers Market Share (%) of Top 5 Players
Figure Global Neurological Biomarkers Market Share (%) of Top 10 Players
Table Thermo Fisher Basic Information List
Table Thermo Fisher Neurological Biomarkers Product Category, Application and Specification
Table Thermo Fisher Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Thermo Fisher Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Thermo Fisher Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Merck Basic Information List
Figure Merck Neurological Biomarkers Product Category, Application and Specification
Table Merck Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Merck Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Merck Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Bio-Rad Laboratories Basic Information List
Figure Bio-Rad Laboratories Neurological Biomarkers Product Category, Application and Specification
Table Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bio-Rad Laboratories Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Bio-Rad Laboratories Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Roche Basic Information List
Figure Roche Neurological Biomarkers Product Category, Application and Specification
Table Roche Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Roche Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Roche Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table QIAGEN Basic Information List
Figure QIAGEN Neurological Biomarkers Product Category, Application and Specification
Table QIAGEN Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure QIAGEN Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure QIAGEN Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Athena Diagnostics Basic Information List
Figure Athena Diagnostics Neurological Biomarkers Product Category, Application and Specification
Table Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Athena Diagnostics Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Athena Diagnostics Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Myriad RBM Basic Information List
Figure Myriad RBM Neurological Biomarkers Product Category, Application and Specification
Table Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Myriad RBM Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Myriad RBM Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Cisbio Bioassays Basic Information List
Figure Cisbio Bioassays Neurological Biomarkers Product Category, Application and Specification
Table Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Cisbio Bioassays Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Cisbio Bioassays Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Wuxi APP Basic Information List
Figure Wuxi APP Neurological Biomarkers Product Category, Application and Specification
Table Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Wuxi APP Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure Wuxi APP Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table BGI Basic Information List
Figure BGI Neurological Biomarkers Product Category, Application and Specification
Table BGI Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure BGI Neurological Biomarkers Sales Growth Rate (2013-2018)
Figure BGI Neurological Biomarkers Sales Global Market Share (%)(2013-2018)
Table Aepodia Basic Information List
Table Genewiz Basic Information List
Table Proteome Sciences Basic Information List
Table Global Neurological Biomarkers Market Size Comparison by Regions (2013-2025)
Figure North America Neurological Biomarkers Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Neurological Biomarkers Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Neurological Biomarkers Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Neurological Biomarkers Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Neurological Biomarkers Sales (K Units) by Regions (2013-2018)
Table Global Neurological Biomarkers Sales Market Share (%) by Regions (2013-2018)
Figure Global Neurological Biomarkers Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Neurological Biomarkers Sales Market Share (%) by Regions
Table Global Neurological Biomarkers Revenue (Million USD) by Regions (2013-2018)
Table Global Neurological Biomarkers Revenue Market Share (%) by Regions (2013-2018)
Figure Global Neurological Biomarkers Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Neurological Biomarkers Revenue Market Share (%) by Regions
Table Global Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure North America Neurological Biomarkers Sales Growth Rate
Table North America Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure United States Neurological Biomarkers Sales (K Units)(2013-2018)
Figure United States Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Canada Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Canada Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Mexico Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Mexico Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Europe Neurological Biomarkers Sales Growth Rate
Table Europe Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Germany Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Germany Neurological Biomarkers Revenue (Million USD) (2013-2018)
Figure UK Neurological Biomarkers Sales (K Units)(2013-2018)
Figure UK Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure France Neurological Biomarkers Sales (K Units)(2013-2018)
Figure France Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Italy Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Italy Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Russia Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Russia Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Turkey Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Turkey Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Asia-Pacific Neurological Biomarkers Sales Growth Rate
Table Asia-Pacific Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure China Neurological Biomarkers Sales (K Units)(2013-2018)
Figure China Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Japan Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Japan Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Korea Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Korea Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Southeast Asia Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Indonesia Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Indonesia Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Thailand Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Thailand Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Malaysia Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Malaysia Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Philippines Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Philippines Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Vietnam Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Vietnam Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure India Neurological Biomarkers Sales (K Units)(2013-2018)
Figure India Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Australia Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Australia Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure South America Neurological Biomarkers Sales Growth Rate
Table South America Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Brazil Neurological Biomarkers Sales (K Units)(2013-2018)
Figure Brazil Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Middle East and Africa Neurological Biomarkers Sales Growth Rate
Table Middle East and Africa Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure North Africa Neurological Biomarkers Sales (K Units)(2013-2018)
Figure North Africa Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure GCC Countries Neurological Biomarkers Sales (K Units)(2013-2018)
Figure GCC Countries Neurological Biomarkers Revenue (Million USD)(2013-2018)
Figure Diagnostics Examples
Figure Drug Discovery Examples
Figure Personalized Medicine Examples
Figure Others Examples
Table Global Neurological Biomarkers Sales (K Units) Comparison by Application (2013-2025)
Table Global Neurological Biomarkers Sales (K Units) by Application (2013-2018)
Table Global Neurological Biomarkers Sales Share (%) by Application (2013-2018)
Figure Global Neurological Biomarkers Sales Market Share (%) by Application (2013-2018)
Table North America Neurological Biomarkers Sales (K Units) by Application (2013-2018)
Table North America Neurological Biomarkers Sales Share by Application (2013-2018)
Figure North America Neurological Biomarkers Sales Market Share by Application (2013-2018)
Figure North America Neurological Biomarkers Sales Market Share by Application in 2017
Table Europe Neurological Biomarkers Sales (K Units) by Application (2013-2018)
Table Europe Neurological Biomarkers Sales Share by Application (2013-2018)
Figure Europe Neurological Biomarkers Sales Market Share by Application (2013-2018)
Figure Europe Neurological Biomarkers Sales Market Share by Application in 2017
Table Asia-Pacific Neurological Biomarkers Sales (K Units) by Application (2013-2018)
Table Asia-Pacific Neurological Biomarkers Sales Share by Application (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Application in 2017
Table South America Neurological Biomarkers Sales (K Units) by Application (2013-2018)
Table South America Neurological Biomarkers Sales Share by Application (2013-2018)
Figure South America Neurological Biomarkers Sales Market Share by Application (2013-2018)
Figure South America Neurological Biomarkers Sales Market Share by Application in 2017
Table Middle East and Africa Neurological Biomarkers Sales (K Units) by Application (2013-2018)
Table Middle East and Africa Neurological Biomarkers Sales Share by Application (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Application (2013-2018)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Application in 2017
Figure Global Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Neurological Biomarkers Sales (K Units) Forecast by Regions (2018-2025)
Figure Global Neurological Biomarkers Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure North America Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure China Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Japan Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Japan Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Korea Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Korea Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Southeast Asia Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Southeast Asia Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure India Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure India Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Australia Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Australia Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure South America Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure North Africa Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure North Africa Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Figure GCC Countries Neurological Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure GCC Countries Neurological Biomarkers Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Neurological Biomarkers Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Neurological Biomarkers Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Neurological Biomarkers Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Neurological Biomarkers Revenue Market Share (%) Forecast by Type (2018-2025)
Figure Proteomics Sales Growth Forecast
Figure Genomics Sales Growth Forecast
Table Global Neurological Biomarkers Sales (K Units) Forecast by Application (2018-2025)
Figure Global Neurological Biomarkers Sales Forecast by Application (2018-2025)
Figure Global Neurological Biomarkers Sales (K Units) Forecast in Diagnostics
Figure Global Neurological Biomarkers Sales (K Units) Forecast in Drug Discovery
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Neurological Biomarkers Manufacturing Cost Structure
Figure Neurological Biomarkers Industrial Chain Analysis
Table Distributors List
Table Neurological Biomarkers Downstream Customers